Navigation Links
Universal Amplicon Detection Assay - Colorimetric from CHEMICON

ProductsUniversal Amplicon Detection Assay - Colorimetric from CHEMICON
Company CHEMICON
Item Universal Amplicon Detection Assay - Colorimetric
Price $275.00
Description The Light Diagnostics Universal Amplicon Detection Assay (ADA) is intended for use in the qualitative detection and quantitation of DNA generated by in vitro nucleic acid amplification. For research use only; not to be used in diagnostic or therapeutic procedures.
Info CHEMICONCHEMICON
CHEMICON International, Inc.
28820 Single Oak Drive
Temecula, CA 92590
Customer Service: 800-437-7500
Tech Support: 800-437-7500
Fax Number: 800-437-7502
Web Site: http://www.chemicon.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Horizontal Laminar Flow Work Station from Terra Universal, Inc.
2. MetaVue from Universal Imaging Corporation (a subsidiary of Molecular Devices)
3. GenePix Pro from Universal Imaging Corporation (a subsidiary of Molecular Devices)
4. MetaMorph from Universal Imaging Corporation (a subsidiary of Molecular Devices)
5. Benchtop Laminar Hood (Universal Hood) from Terra Universal, Inc.
6. Benchtop Laminar Flow Hood (Environmental Control Module) from Terra Universal, Inc.
7. Vertical Laminar Flow Work Station from Terra Universal, Inc.
8. Down Draft Work Station from Terra Universal, Inc.
9. Heated Processing Chamber from Terra Universal, Inc.
10. Pharmaceutical Compounding Chamber from Terra Universal, Inc.
11. Benchtop Ductless Exhaust Hood (Universal Hood) from Terra Universal, Inc.
Rat Epidermal Keratinocytes (REK) (>500,000 cells)...
anti-Yan 8B12H9...
sPLA2-XII Human, Rabbit Polyconal Antibody Anti-Human sPLA2-XII Antibody was raised in rabbits against Human sPLA2-XII His-Tagged Fusion Protein Antigen: The recombinant human protein sPLA-XII...
... Expand the computing power of your ValveBank system! ... with a PC computer running Windows 98, 2000, ... unlimited programs to disk, print out program listings, ... in one simple step., EasyCode is used for ...
Biology Products:
(Date:7/7/2015)... June 30, 2015 ... the addition of the "Capacitive Fingerprint Sensors ... To this date, fingerprint sensing technology is ... fingerprint sensors are well developed. This patent landscape ... The domain of capacitive fingerprint sensors ...
(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:6/30/2015)... , June 30, 2015 To bolster its ... provider HYPR Corp. announced today the addition of two new ... serve as board advisor and David Raviv will ... team underscore HYPR Corp.,s commitment to providing the most secure ... Dimitri Sirota co-founded Layer 7 Technologies, a provider of ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... team has found a way to stabilize hemoglobin, the ... could lead to the development of stable vaccines and ... involves wrapping the polymer poly(acrylic acid) around hemoglobin, protecting ... allowing it to maintain its biological function and structural ...
... development along the edges of most public forests in Oregon ... study conducted by the U.S. Forest Service Pacific,s Northwest (PNW) ... photography to inventory structures at the fringes of public forests, ... two states before and after the enactment of land use ...
... and Cellular Plasticity symposium will focus on how epigenetic ... lead to cellular plasticity. WHEN/WHERE: Thursday ... Center of the National Academies of Sciences and Engineering ... to attend should contact Catherine Cao at cepmet@uci.edu ...
Cached Biology News:New method for stabilizing hemoglobin could lead to stable vaccines, artificial blood 2New method for stabilizing hemoglobin could lead to stable vaccines, artificial blood 3Development near Oregon, Washington public forests 2Top scientists to present at Epigenetic Control and Cellular Plasticity symposium 2
(Date:7/30/2015)... , July 30, 2015 According ... Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity ... Development, Preclinical, Clinical Trial), by End Users - Global ... is expected to reach USD 2,107.99 million by 2020 ... of 15.29%. Browse more than ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
(Date:7/29/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today ... Financial Officer has resigned.  The Company has hired ... retired in December 2014, as full time interim CFO ... Andy Ashworth began his employment ... smooth transition.  Andy was the Company,s CFO from September ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3